Shenzhen Yhlo Biotech Co., Ltd. (688575.SH) announced that the company and its wholly-owned subsidiary, Hunan Yhlo Biotech Co., Ltd., recently received medical device registration certificates issued by the Guangdong and Hunan Provincial Medical Products Administrations. The registered products include the Salivary Gland Tumor-Associated Antigen (KL-6) Assay Kit (Chemiluminescence Method) and the Anti-Melanoma Differentiation-Associated Gene 5 IgG Antibody Assay Kit (Chemiluminescence Method).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.